XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.1
Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Bad debt expense $ 0 $ 0  
Increase (Decrease) in Inventories $ 1,132 (34,730)  
Lease term 12 months    
Amortization expense $ 4,050 4,050 $ 4,050
Net operating loss carry-forwards 23,800,000 21,800,000  
Advertising and Marketing Costs 111,104 112,036  
Research and development expenses $ 598,810 624,564  
Description of patent straight-line basis over the estimated useful life of 10 years    
Impaired and written-off $ 0 0  
Patents [Member]      
Accumulated amortization $ 8,100 $ 4,050  
Convertible Notes Payable - Related Party [Member]      
Potential antidilutive shares 3,747,463 2,338,832  
Convertible Notes Payable [Member]      
Potential antidilutive shares 1,483,530 925,887  
Restricted Stock Units [Member]      
Potential antidilutive shares 47,665,000 47,665,000  
Sales Revenue Net [Member] | One Customer [Member]      
Concentration of credit risk   100.00%